Injection site-dependent induction of immune response by DNA vaccine: Comparison of skin and spleen as a target for vaccination

Journal of Gene Medicine

Volumn 12, Issue 3, 2010, Pages 301-309

  Guan, Xin ^a   Nishikawa, Makiya ^a   Takemoto, Seiji ^a   Ohno, Yuji ^a   Yata, Tomoya ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antigen specific immune response; Gene transfer; Intradermal injection; Intrasplenic injection; Plasmid DNA; Tumor immunotherapy

Indexed keywords

DNA VACCINE; EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN G; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; PLASMID DNA; PLASMID VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCING CELL; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; ELECTROPORATION; FEMALE; GENE TRANSFER; IMMUNOREACTIVITY; INJECTION SITE; INTERFERON PRODUCTION; INTRASPLENIC DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; TRANSGENE; TUMOR IMMUNOLOGY;

ANIMALS; ANTIBODY FORMATION; ELECTROPORATION; FEMALE; IMMUNOGLOBULIN G; INJECTIONS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; PLASMIDS; SKIN; SPLEEN; VACCINATION; VACCINES, DNA;

MUS;

EID: 77349106467     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1432     Document Type: Article

References (31)

1. Kawase A, Isaji K, Yamaoka A, et al. Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice. Vaccine 2006; 24: 5535-5545.
2. Joanna RK, Robert AS. DNA vaccination: the answer to stable, protective T-cell memory? Curr Opin Immunol 2003; 15: 471-476.
3. Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000; 18: 927-974.
4. Nishikawa M, Leaf H. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001; 12: 861-870.
5. Horton HM, Lalor PA, Rolland AP. IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial. Methods Mol Biol 2008; 423: 361-372.
6. Timmerman JM, Singh G, Hermanson G, et al. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. Cancer Res 2002; 62: 5845-5852.
7. Mäkinen K, Manninen H,Hedman M, et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebocontrolled, double-blinded phase II study. Mol Ther 2002; 6: 127-133.
8. Hartikka J, Geall A, Bozoukova V, et al. Physical characterization and in vivo evaluation of poloxamer-based DNA vaccine formulations. J Gene Med 2008; 10: 770-782.
9. Somiari S, Glasspool-Malone J, Drabick JJ, et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000; 2: 178-187.
10. Jaroszeski MJ, Gilbert R, Nicolau C, et al. In vivo gene delivery by electroporation. Adv Drug Deliv Rev 1999; 35: 131-137.
11. Thanaketpaisarn O, Nishikawa M, Yamashita F, et al. Tissuespecific characteristics of in vivo electric gene: transfer by tissue and intravenous injection of plasmid DNA. Pharm Res 2005; 22: 883-891.
12. Peachman KK, Rao M, Alving CR. Immunization with DNA through the skin. Methods 2003; 31: 232-242.
13. Mebius RE, Kraal G. Struture and function of the spleen. Nat Rev Immunol 2005; 5: 606-616.
14. Maioli TU, Carneiro CM, Assis FA, et al. Splenectomy does not interfere with immune response to Leishmania major infection in mice. Cell Immunol 2007; 249: 1-7.
15. Cayeux S, Qin Z, Dörken B, et al. Decreased generation of antitumor immunity after intrasplenic immunization. Eur J Immunol 2001; 31: 1392-1399.
16. + T cell responses in gene gun DNA immunization. J Immunol 2001; 167: 5549-5557.
17. Corr M, von Damm A, Lee DJ, et al. In vivo priming by DNA injection occurs predominantly by antigen transfer. J Immunol 1999; 163: 4721-4727.
18. Doe B, Selby M, Barnett S, Baenziger J, Walker CM. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 1996; 93: 8578-8583.
19. Fu TM, Ulmer JB, Caulfield MJ, et al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 1997; 3: 362-371.
20. Isaji K, Kawase A, Matono M, et al. Enhanced CTL response by controlled intracellular trafficking of antigen in dentritic cells following DNA vaccination. J Control Release 2009; 135: 227-233.
21. Maecker HT, Umetsu DT, DeKruyff RH, et al. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin. Vaccine 1997; 15: 1687-1696.
22. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54: 777-785.
23. Hyoudou K, Nishikawa M, Kobayashi Y, et al. Analysis of in vivo nuclear factor-κB activation during liver inflammation in mice: prevention by catalase delivery. Mol Pharmacol 2007; 71: 446-453.
24. Chonn A, Semple SC, Cullis PR. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem 1992; 267: 18759-18765.
25. Ito D, Ogasawara K, Iwabuchi K, et al. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb. J Immunol 2000; 164: 1230-1235.
26. McCullough KC, Summerfield A. Basic concepts of immune response and defense development. ILAR J 2005; 46: 230-240.
27. Bins AD, Wolkers MC, van den Boom MD, et al. In vivo antigen stability affects DNA vaccine immunogenicity. J Immunol 2007; 179: 2126-2133.
28. Babiuk S, Baca-Estrada M, Babiuk LA, et al. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release 2000; 66: 199-214.
29. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
30. Tupin E, Poirier B, Bureau MF, et al. Non-viral gene transfer of murine spleen cells achieved by in vivo electroporation. Gene Ther 2003; 10: 569-579.
31. Maloy KJ, Erdmann I, Basch V, et al. Intralymphatic immunization enhances DNA vaccination. Proc Natl Acad Sci USA 2001; 98: 3299-3303.